Addressing Unmet Needs With Injectable Medications in Type 2 Diabetes Treatment: Role of Injectable Medications in Type 2 Diabetes Treatment
Miller, E.M.
Journal of Family Practice 66(10 Suppl): S4-S6
2017
ISSN/ISBN: 0094-3509 PMID: 28991930 Document Number: 17040
Current treatment guidelines for patients with T2DM recommend key roles for basal insulin and GLP-IRAs across the spectrum of the disease. These recommendations are based on efficacy and safety data as well as other benefits observed in clinical trials.
Document emailed within 1 workday
Related Documents
Getzen, H.; Beasley, M.; D'Mello, D.A. 2013: Barriers to utilizing long-acting injectable antipsychotic medications Annals of Clinical Psychiatry: Official Journal of the American Academy of Clinical Psychiatrists 25(4): E1-E6Weiss, R.; Bazalo, G.; Clark, N.; Forma, F.; Ingram, G.; Alemayehu, B. 2007: Correlation of HEDIS diabetes health plan score with utilization of diabetes medications Managed Care Interface 20(10): 14-17
Zathurecky, L.; Bauerova, O.; Somoskeoey, G.; Molnar, L.; Suchy, S. 1963: Stability of Cardenolides of the Strophanthidin type in Injectable Preparations. Iii. Preparations of Stable Injectable Solutions of Helveticoside Ceskoslovenska Farmacie 12: 171-177
Philippe, J. 2009: Role and indication of GLP-1 analogues in the treatment of type 2 diabetes Revue Medicale Suisse 5(206): 1260-1262; 1264-1265
Scheen, A.J. 2015: How i TREAT ... THE ROLE OF DPP-4 INHIBITORS (GLIPTINS) IN THE TREATMENT OF TYPE 2 DIABETES Revue Medicale de Liege 70(12): 593-599
Gorus, F.K. 1996: The importance of diabetes registries and clinical biology for the study and treatment of type 1 (insulin-dependent) diabetes mellitus Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 58(5): 539-586
Urakami, T.; Suzuki, J.; Mugishima, H.; Amemiya, S.; Sugihara, S.; Kawamura, T.; Kikuchi, T.; Sasaki, N.; Matsuura, N.; Kitagawa, T. 2012: Screening and treatment of childhood type 1 and type 2 diabetes mellitus in Japan Pediatric Endocrinology Reviews: Per 10(Suppl 1): 51-61
Snarski, E.; Milczarczyk, A.; Franek, E.; Jedrzejczak, W. 2010: Potential role of immunoablation and hematopoietic cell transplantation in the treatment of early diabetes type 1 Annals of Transplantation 15(3): 75-79
Wadström, J.; Gannedahl, G.; Wahlberg, J.; Frödin, L.; Tedbrandt, A.; Berne, C. 1994: Development of type Ii diabetes after combined kidney-pancreas transplantation in a patient with type i (insulin-dependent) diabetes Transplantation Proceedings 26(3): 1761-1762
De Sanctis, V. 2018: Type 1 and Type 2 diabetes in children and adolescents: a public health problem in Qatar. The experience of Pediatric Diabetes Center at Hamad General Hospital (HGH) of Doha Acta Bio-Medica: Atenei Parmensis 89(S5): 5-6
Tuomilehto, J.; Lindström, J. 2003: The principal trials for prevention of type 2 diabetes have now confirmed that type 2 diabetes can be prevented by life style changes. Prevention of type 2 diabetes by life style Journees Annuelles de Diabetologie de l'Hotel-Dieu 2003: 77-89
Stransky, M.L. 2018: Unmet Needs for Care and Medications, Cost as a Reason for Unmet Needs, and Unmet Needs as a Big Problem, due to Health-Care Provider (Dis)Continuity Journal of Patient Experience 5(4): 258-266
Likitmaskul, S.; Wacharasindhu, S.; Rawdaree, P.; Ngarmukos, C.; Deerochanawong, C.; Suwanwalaikorn, S.; Chetthakul, T.; Bunnag, P.; Kosachunhanun, N.; Plengvidhaya, N.; Leelawatana, R.; Krittiyawong, S.; Benjasuratwong, Y.; Pratipanawatr, T. 2006: Thailand diabetes registry project: type of diabetes, glycemic control and prevalence of microvascular complications in children and adolescents with diabetes Journal of the Medical Association of Thailand 89(Suppl 1): S10-S16
Lervang, H.H. 2001: Type 2 diabetes--new treatment Ugeskrift for Laeger 163(44): 6101
Silecchia, G.; Casella, G.; Rizzello, M. 2009: Surgical treatment of type 2 diabetes Acta Chirurgica Belgica 109(3): 292-299
Davidson, M.B. 2002: Treatment decisions for type 2 diabetes JAMA 287(13): 1646-7; author reply 1647-8
Novak, B.; Metelko, Z. 2011: Liraglutide in the treatment of diabetes type 2 Lijecnicki Vjesnik 133(7-8): 269-276
Thorsby, P.; Kilhovd, B.; Sletmo, R.; Martinsen, S.; Birkeland, K.I. 2000: Hypoglycemic treatment of type 2 diabetes Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 120(20): 2434-2440
Ostgren, C.J.; Eliasson, B.ör. 2008: Who should be responsible for the treatment of type 2 diabetes? Lakartidningen 105(36): 2432-2433
Reinke, T. 2012: New diabetes medications drive up costs and stymie formulary design Managed Care 21(4): 16-18